Literature DB >> 10686017

A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A.

R Dal-Ré1, P García-Corbeira, J García-de-Lomas.   

Abstract

A seroepidemiological study was conducted to assess the seroprevalence of hepatitis A (HAV) antibodies in the Spanish general population in 1992-93. A total of 2744 subjects (1337 men and 1437 women) in the 5-59 years age range were stratified by gender and age (5-12, 13-19, 20-29, 30-39, 40-49, 50-59 years). The presence of total anti-HAV antibodies was investigated using a commercial enzyme immunoassay. Fifty-five percent (95% CI: 53.5-57. 2%) of the subjects were positive for anti-HAV antibodies, the age-standardized anti-HAV prevalence being 65.4%. Prevalence of seropositive subjects increased with increasing age (chi(2) = 996, 17; P < 0.0001), being 11%, 25% and 54% for the 5-12, 13-19 and 20-29 age groups respectively. The results from this study showed a remarkable decline in seroprevalence rates among children, adolescents and young adults. The large number of susceptible subjects in these groups of the population has public health implications in a country with intermediate HAV prevalence. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686017

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Distribution of human virus contamination in shellfish from different growing areas in Greece, Spain, Sweden, and the United Kingdom.

Authors:  M Formiga-Cruz; G Tofiño-Quesada; S Bofill-Mas; D N Lees; K Henshilwood; A K Allard; A-C Conden-Hansson; B E Hernroth; A Vantarakis; A Tsibouxi; M Papapetropoulou; M D Furones; R Girones
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

2.  Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.

Authors:  Filippo Ansaldi; Bianca Bruzzone; Maria Cristina Rota; Antonino Bella; Marta Ciofi degli Atti; Paolo Durando; Roberto Gasparini; Giancarlo Icardi
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

3.  Seroprevalence of hepatitis A, B and C markers in Greek warship personnel.

Authors:  E Mazokopakis; J Vlachonikolis; A Philalithis; C Lionis
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

4.  Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004.

Authors:  G Cilla; E Pérez-Trallero; J Artieda; E Serrano-Bengoechea; M Montes; D Vicente
Journal:  Epidemiol Infect       Date:  2006-07-19       Impact factor: 2.451

5.  Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran.

Authors:  Ali Jafari Mehr; Mohammad Javad Ehsani Ardakani; Mehdi Hedayati; Saeed Shahraz; Elnaz Jafari Mehr; Mohammad Reza Zali
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  Hepatitis A, Italy.

Authors:  Raffaele D'Amelio; Alfonso Mele; Andrea Mariano; Luisa Romanò; Roberto Biselli; Florigio Lista; Alessandro Zanetti; Tommaso Stroffolini
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.